1. Home
  2. INN vs KMDA Comparison

INN vs KMDA Comparison

Compare INN & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INN
  • KMDA
  • Stock Information
  • Founded
  • INN 2010
  • KMDA 1990
  • Country
  • INN United States
  • KMDA Israel
  • Employees
  • INN N/A
  • KMDA N/A
  • Industry
  • INN Real Estate Investment Trusts
  • KMDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • INN Real Estate
  • KMDA Health Care
  • Exchange
  • INN Nasdaq
  • KMDA Nasdaq
  • Market Cap
  • INN 490.4M
  • KMDA 399.7M
  • IPO Year
  • INN 2011
  • KMDA N/A
  • Fundamental
  • Price
  • INN $4.90
  • KMDA $7.20
  • Analyst Decision
  • INN
  • KMDA Strong Buy
  • Analyst Count
  • INN 0
  • KMDA 3
  • Target Price
  • INN N/A
  • KMDA $14.67
  • AVG Volume (30 Days)
  • INN 2.2M
  • KMDA 71.8K
  • Earning Date
  • INN 07-28-2025
  • KMDA 08-13-2025
  • Dividend Yield
  • INN 6.57%
  • KMDA 2.77%
  • EPS Growth
  • INN N/A
  • KMDA 31.21
  • EPS
  • INN 0.20
  • KMDA 0.28
  • Revenue
  • INN $728,119,000.00
  • KMDA $167,235,000.00
  • Revenue This Year
  • INN $2.92
  • KMDA $14.51
  • Revenue Next Year
  • INN $2.49
  • KMDA $9.31
  • P/E Ratio
  • INN $24.02
  • KMDA $26.07
  • Revenue Growth
  • INN N/A
  • KMDA 11.83
  • 52 Week Low
  • INN $3.57
  • KMDA $4.74
  • 52 Week High
  • INN $7.22
  • KMDA $9.16
  • Technical
  • Relative Strength Index (RSI)
  • INN 64.65
  • KMDA 65.83
  • Support Level
  • INN $4.51
  • KMDA $6.78
  • Resistance Level
  • INN $4.83
  • KMDA $7.09
  • Average True Range (ATR)
  • INN 0.17
  • KMDA 0.16
  • MACD
  • INN 0.05
  • KMDA 0.04
  • Stochastic Oscillator
  • INN 91.14
  • KMDA 98.48

About INN Summit Hotel Properties Inc.

Summit Hotel Properties Inc is a U.S.-based hotel investment company focusing on select-service hotels in the upscale and upper-midscale properties in the U.S. Substantially all of Summit's assets are held and operated by its Operating Partnership, Summit Hotel OP, LP, in which the company holds general and limited partnership interests. The firm has one segment in activities related to investing in real estate. Summit's revenue streams include Room and Other hotel operations revenue. Room comprises the majority of total revenues. The firm's hotels are located in various markets, such as corporate offices, retail centers, airports, state capitols, convention centers, and leisure attractions. Summit's hotels operate under brands, including Marriott, Hilton, Hyatt, and Holiday Inn.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: